CycleSense
Track your period pain and bleeding patterns over 2-3 cycles, get a plain-language read on whether endometriosis might be worth investigating, and find a certified endometriosis center near you — built for women who've spent years being told to just 'ride it out.'
women aged 16-40 in German-speaking countries with severe menstrual pain who suspect something beyond 'normal cramps'
- Daily pain and bleeding log with cycle-phase overlay and a quick 0-10 pain scale
- Self-assessment against common endometriosis markers: dysmenorrhea severity, GI symptoms, pain location, family history
- Verified specialist directory of certified endometriosis centers (e.g., the Aschaffenburg Zentrum surfaced in the trend) with wait times
- One-click PDF summary to bring to a gynecologist appointment, in plain medical German
A Bavarian school talk on endometriosis just went mildly viral in Germany, and the average diagnosis delay is still 7-10 years — women need a structured way to walk into a doctor's appointment with evidence instead of vague complaints.
10-15% of German women aged 15-49 are affected (millions of patients), diagnostic delay averages ~10 years in Germany, and 'Endometriose' sits in the 100+ band on Google Trends DE — confirmed by University of Witten/Herdecke and a 2024 BJOG systematic review.Endometriosis Day: Millions of women affected – diagnosis takes an average of 10 years ↗Time to Diagnose Endometriosis: Current Status, Challenges and Regional Characteristics—A Systematic Literature Review ↗
The DACH endometriosis-tracker niche already has multiple incumbents: the DiGA-listed Endo-App (€235.80, listed since 10/2022), tr8ck.health, the Lunaire Endo-Tracker, plus a generic Endometriose-Tracker on Google Play — and BARMER itself actively promotes an endometriosis app, so the plain tracking layer is fairly contested.Endo-App | HealthOn (Herstellerpreis 235,80 €, gelistet seit 10.10.2022) ↗App bei Regelschmerzen und Endometriose | BARMER ↗
Germany's DiGA pathway exists with a clear pricing precedent: the Endo-App is reimbursed at €235.80 per prescription and listed permanently since Oct 2022, and BARMER (a major statutory insurer) is already funding/promoting a competing endometriosis app — a pre-diagnosis screening + specialist-finder could plausibly follow the same reimbursement route.Endo-App im DiGA-Verzeichnis (Herstellerpreis 235,80 €) ↗Endo-App bei Endometriose | DiGA-Verzeichnis ↗
Endometriosis is a chronic, lifelong condition with structurally entrenched 7–10 year diagnosis delays (consistent across 2010–2024 studies), public awareness is rising (e.g., viral Bavarian school talk), and the DiGA framework means a well-built tool can stay permanently listed and reimbursed rather than fading as a trend.Endometriosis Day: Millions of women affected – diagnosis takes an average of 10 years ↗Diagnostic delay in endometriosis: is there any progress? ↗
A plain-language 'screen for suspected endo' feature plus a curated center directory is non-trivial: it sits near medical-device / DiGA / MDR regulatory territory in Germany (the Endo-App took years to clear listing), needs partnerships with certified Endometriosezentren, and requires multi-month BfArM approval work to monetize via prescription — even though the tracker UI itself is straightforward.Drei Wege zur Endo-App (DiGA pathway explainer) ↗Endo-App Herstellerpreis 235,80 €, gelistet 10.10.2022 ↗